Skip to content

Mechanistic Study of Oxidative Stress Participating in Endometriosis Fibrosis by Activating the cGAS-STING Pathway in Endometriotic Lesions via Mitochondrial Damage

Mechanistic Study of Oxidative Stress Participating in Endometriosis Fibrosis by Activating the cGAS-STING Pathway in Endometriotic Lesions via Mitochondrial Damage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120800
Enrollment
Unknown
Registered
2026-03-19
Start date
2026-03-19
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Case group:None
Control group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1. Female individuals aged 18-49 years old; 2. Meeting the criteria for the control group or case group: Control group: No history of endocrine diseases. No history of hormone replacement therapy or no use of contraceptive pills and hormone-based drugs in the past 3 months. No metabolic, blood circulation, or systemic chronic diseases. No history of radiotherapy or chemotherapy. Not pregnant or in lactation. No excessive alcohol consumption in the past 3 months, or no long-term blood donation or blood transfusion. No reproductive organ deformities or ovarian surgeries, etc. Case group: Patients diagnosed with ovarian-type endometriosis by histological examination; 3. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Has a history of endocrine disorders. 2. Has a history of hormone replacement therapy or has taken contraceptive pills and hormone-based drugs in the past 3 months. 3. Has metabolic, circulatory, or systemic chronic diseases throughout the body. 4. Has a history of radiotherapy or chemotherapy. 5. Is pregnant or breastfeeding. 6. Has consumed large amounts of alcohol in the past 3 months, or has engaged in long-term blood donation or blood transfusion. 7. Has genital deformities or undergone ovarian surgery, etc.

Design outcomes

Primary

MeasureTime frame
To elucidate the regulatory relationship between the cGAS-STING pathway and endometriosis fibrosis at the tissue and cellular levels.;

Secondary

MeasureTime frame
Therapeutic targets for patients with endometriosis;

Countries

China

Contacts

Public ContactLiu Yi

Wuhan Union Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology

liqun94@163.com+86 13971038710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026